Sylogist Ltd.
SYZLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0.1% | -5.1% | 78.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 58.8% | 44.9% | 44.4% | 72.3% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 11.7% | 16.9% | 22.3% | 37.5% |
| Net Income | -$0 | $0 | $0 | $0 |
| % Margin | -1.1% | 1.7% | 3.7% | 11.3% |
| EPS Diluted | -0.031 | 0.047 | 0.11 | 0.18 |
| % Growth | -166.9% | -57.7% | -38.9% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |